In this issue of Clinics in Perinatology, guest editors Drs. Satyanarayana Lakshminrusimha and Steve Abman bring their considerable expertise to the topic of Neonatal Pulmonary Hypertension. About one in every 1,250 newborns develop neonatal pulmonary hypertension, and about 25% of survivors will have developmental delays, hearing problems, and/or functional disabilities. In this issue, top experts provide updates to the perinatologist on managing this condition to improve patient outcomes.
1. Cover image - p. i 2. Title page - p. i 3. Table of Contents - p. i 4. Copyright - p. ii 5. Contributors - p. iii 6. CME Accreditation Page - p. xi 7. Forthcoming Issues - p. xiii 8. Foreword - p. xv 9. Preface - p. xix 10. Pulmonary Vascular Regulation in the Fetal and Transitional Lung - p. 1 11. Pathogenesis and Physiologic Mechanisms of Neonatal Pulmonary Hypertension: Preclinical Studies - p. 21 12. Targeted Neonatal Echocardiography in the Management of Neonatal Pulmonary Hypertension - p. 45 13. Oxygen Targets in Neonatal Pulmonary Hypertension: Individualized, “Precision-Medicine” Approach - p. 77 14. Inhaled Nitric Oxide in Neonatal Pulmonary Hypertension - p. 95 15. Targeted Therapies for Neonatal Pulmonary Hypertension: Beyond Nitric Oxide - p. 113 16. Asphyxia, Therapeutic Hypothermia, and Pulmonary Hypertension - p. 127 17. Congenital Diaphragmatic Hernia: Pulmonary Hypertension and Pulmonary Vascular Disease - p. 151 18. Early Pulmonary Hypertension in Preterm Infants - p. 171 19. Pulmonary Hypertension in Established Bronchopulmonary Dysplasia: Physiologic Approaches to Clinical Care - p. 195 20. Pulmonary Hypertension in Developmental Lung Diseases - p. 217 21. Etiology, Diagnosis and Management of Persistent Pulmonary Hypertension of the Newborn in Resource-limited Settings - p. 237 22. Randomized Controlled Trials of Pulmonary Vasodilator Therapy Adjunctive to Inhaled Nitric Oxide for Persistent Pulmonary Hypertension of the Newborn: A Systematic Review - p. 253 23. Comorbidities and Late Outcomes in Neonatal Pulmonary Hypertension - p. 271
In this issue of Clinics in Perinatology, guest editors Drs. Satyanarayana Lakshminrusimha and Steve Abman bring their considerable expertise to the topic of Neonatal Pulmonary Hypertension. About one in every 1,250 newborns develop neonatal pulmonary hypertension, and about 25% of survivors will have developmental delays, hearing problems, and/or functional disabilities. In this issue, top experts provide updates to the perinatologist on managing this condition to improve patient outcomes.
1. Cover image - p. i 2. Title page - p. i 3. Table of Contents - p. i 4. Copyright - p. ii 5. Contributors - p. iii 6. CME Accreditation Page - p. xi 7. Forthcoming Issues - p. xiii 8. Foreword - p. xv 9. Preface - p. xix 10. Pulmonary Vascular Regulation in the Fetal and Transitional Lung - p. 1 11. Pathogenesis and Physiologic Mechanisms of Neonatal Pulmonary Hypertension: Preclinical Studies - p. 21 12. Targeted Neonatal Echocardiography in the Management of Neonatal Pulmonary Hypertension - p. 45 13. Oxygen Targets in Neonatal Pulmonary Hypertension: Individualized, “Precision-Medicine” Approach - p. 77 14. Inhaled Nitric Oxide in Neonatal Pulmonary Hypertension - p. 95 15. Targeted Therapies for Neonatal Pulmonary Hypertension: Beyond Nitric Oxide - p. 113 16. Asphyxia, Therapeutic Hypothermia, and Pulmonary Hypertension - p. 127 17. Congenital Diaphragmatic Hernia: Pulmonary Hypertension and Pulmonary Vascular Disease - p. 151 18. Early Pulmonary Hypertension in Preterm Infants - p. 171 19. Pulmonary Hypertension in Established Bronchopulmonary Dysplasia: Physiologic Approaches to Clinical Care - p. 195 20. Pulmonary Hypertension in Developmental Lung Diseases - p. 217 21. Etiology, Diagnosis and Management of Persistent Pulmonary Hypertension of the Newborn in Resource-limited Settings - p. 237 22. Randomized Controlled Trials of Pulmonary Vasodilator Therapy Adjunctive to Inhaled Nitric Oxide for Persistent Pulmonary Hypertension of the Newborn: A Systematic Review - p. 253 23. Comorbidities and Late Outcomes in Neonatal Pulmonary Hypertension - p. 271
